Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses


We provide an integrated approach to the regulatory and transactional issues that arise in the context of lending and private equity sponsor transactions. In particular, we bring a deep understanding of the embedded regulatory matters to provide a thorough due diligence analysis of a target company’s operations identifying potential regulatory and legal risks and cash flow disruptions. Our analysis includes reviewing compliance with federal Medicare and Medicaid laws and regulations and state law correlates, and providing advice regarding the potential impact on the future value of the business model. In circumstances where areas of concern arise, we help our clients correct issues and suggest alternative deal structures as appropriate, enabling the deal to go forward while avoiding potential cash flow disruption or prolonged legal actions post closing.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.